A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

  • STATUS
    Recruiting
  • participants needed
    50
  • sponsor
    Kaleido Biosciences
Send
Updated on 16 February 2024
See if I qualify

Summary

This exploratory, open-label clinical study aims to explore the physiologic effects of KB109, a novel glycan, on adult patients with COVID-19 illness on gut microbiota structure and function in the outpatient setting.

Details
Condition Mild-to-Moderate COVID-19
Age 18years - 100years
Treatment KB109 + Self Supportive Care (SSC), Self Supportive Care (SSC) Alone
Clinical Study IdentifierNCT04486482
SponsorKaleido Biosciences
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Be male or female, 18 years of age
Be willing and able to give informed consent
Screening/Randomization telemedicine visit within 2 days of testing positive test for COVID-19
Having self-reported fever or cough for not more than 72 hours prior to COVID-19 testing
Mild to moderate COVID-19
Able to adhere to the study visit schedule and other protocol requirements
Patients who meet any of the following Exclusion Criteria at the Randomization
Visit will not be enrolled into the study
Patients who are hospitalized for in-patient treatment or currently being evaluated for potential hospitalization at the time of informed consent for conditions other than COVID-19
History of chronic lung disease
Ongoing requirement for oxygen therapy
Shortness of breath in resting position
Diagnosis of sleep apnea requiring Bilevel Positive Airway Pressure (BIPAP) / Continuous Positive Airway Pressure (CPAP)
Female patients who are pregnant, trying to become pregnant or lactating
Is considered, in the opinion of the PI, to be unlikely for any reason to be able to comply with study procedures
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.